CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $487.37 | $195K | 36,781 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 20,250 | ||
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $483.12 | $725K | 2,630 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,976 | $484.30 | $957K | 654 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −524 | $485.14 | $254K | 130 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 22,000 | ||
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $477.92 | $478K | 3,130 |
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,600 | $480.17 | $768K | 1,530 |
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $480.71 | $192K | 1,130 |
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $481.72 | $482K | 130 |
| 2025-12-10 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 26,000 | ||
| 2025-12-09 | Mesa Nilda Director | Sale | −187 | $481.63 | $90K | 5,286 |
| 2025-12-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,440 | $477.63 | $1.2M | 1,690 |
| 2025-12-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,560 | $479.33 | $748K | 130 |
| 2025-12-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 30,000 | ||
| 2025-12-08 | ROTHBLATT MARTINE A Chairperson & CEO | Gift 10b5-1 | −5,000 | 10,962 | ||
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
Page 172 of 214 · 4,273 trades